<DOC>
	<DOCNO>NCT02886182</DOCNO>
	<brief_summary>To date , several study manifest high level adrenal corticosteroid oestrogen hormone pregnancy lead increase HBV viraemia . These hormonal immune function status change result minimal fluctuation liver function test . Serum alanine aminotransferase ( ALT ) tend increase late pregnancy postpartum period . Peripartum hepatitis flare lead hepatic decompensation reported.Therefore , investigator aim detect observe immune function status incidence hepatitis pregnant woman chronic hepatitis B virus infection late pregnancy postpartum period.To provide clinical evidence administration chronic hepatitis B virus infection pregnant woman .</brief_summary>
	<brief_title>Immune Function Status Prevalence Hepatitis Postpartum Pregnant Women With CHB Infection</brief_title>
	<detailed_description>In trial , pregnants positivity serum HBsAg 6 month HBeAg , HBV DNA &gt; 106IU/mL , alanine aminotransferase ( ALT ) 35 IU/mL ( ULN=40IU/mL ) receive nucleoside analogue antiviral therapy enrol group A , In addition , CHB infection pregnants undetectable HBVDNA enrol group B ( control group ) .In , pregnants chronic HBV infection without compensated cirrhosis , hepatic adipose infiltration , ICP , hypertension , heart disease , postpartum hemorrhage . None mother co-infected hepatitis A , C , D , E , HIV ; syphilis , Epstein-Barr virus.Serum HBV DNA load ( Roche , Pleasanton , CA , USA ) , HBsAg/anti-HBs level , HBeAg/anti-HBe routine blood test , liver function , renal function test piror delivery postpartum 2,6,12 week . plasmacytoid dendritic cell ( pDCs ) natural killer ( NK ) cell , CD4＋T cell regulatory T ( Treg ) cell detect flow cytometry . Plasma cytokines Interferon-alpha 2 ( IFN-α2 ) / Interferon-gamma ( IFN-γ ) / Transforming growth factor beta1 ( TGF-β1 ) / Interleukin-2 ( IL-2 ) / Interleukin-6 ( IL-6 ) /Interleukin-10 ( IL-10 ) / Interleukin-17A ( IL-17A ) / tumor necrosis factor-α1 ( TNF-α1 ) measure Luminex time point except 2 week .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<criteria>pregnants positivity serum HBsAg 6 month HBeAg , HBV DNA &gt; 106IU/mL/undetectable HBVDNA , alanine aminotransferase ( ALT ) 35 IU/mL ( ULN=40IU/mL ) receive nucleoside analogue antiviral therapy compensate cirrhosis , hepatic adipose infiltration , ICP . hypertension , heart disease . postpartum hemorrhage . pregnants coinfected hepatitis A , C , D , E , HIV ; syphilis , EpsteinBarr virus .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>chronic hepatitis B</keyword>
	<keyword>pregnancy</keyword>
	<keyword>Cellular immune response</keyword>
	<keyword>Clinical implication</keyword>
</DOC>